Skip to content
Back to Guavy Wire
Stocks

Merck Stake Reduced by 4.8% Amid Cancer-Trial Success

Instruments
MRK
Share

Heritage Investors Management Corp has reduced its stake in Merck & Co., Inc. (NYSE:MRK) by 4.8% during the second quarter, according to a recent filing with the Securities & Exchange Commission.

The firm now owns 316,592 shares of the company's stock after selling 15,875 shares during the period, which accounts for approximately 1.1% of Heritage Investors Management Corp's portfolio.

This stake is valued at $40,682,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of MRK during the second quarter.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc